PURPOSE: Although resynchronisation therapy (CRT) is a promising addition to heart failure therapy, a substantial number of patients do not respond to CRT. As FDG PET has routinely been used for prediction of improvement after revascularisation in ischaemic cardiomyopathy, it was hypothesised that there is also a relationship between the extent of viable tissue and improvement as a result of CRT. METHODS: Thirty-nine patients with ischaemic cardiomyopathy (ejection fraction 27 +/- 9%) and a wide QRS complex underwent temporary pacing to determine the optimal pacing combination, i.e. that with the highest increase in cardiac index (CI) compared with baseline (measured by Doppler echocardiography). All patients also underwent FDG PET imaging. In 19 patients, CI measurements were repeated 10-12 weeks after permanent biventricular pacemaker implantation. RESULTS: Echocardiography (13-segment model) showed a mean of 9.8 +/- 1.6 dyssynergic segments, with preserved FDG uptake in 4.1 +/- 2.4 segments. CI improvement at the optimal pacing site was 20 +/- 9%. There was a linear relationship between the extent of viable tissue and CI improvement during pacing (p < 0.001). Using a cut-off value of more than three viable segments (ROC analysis), FDG PET had a sensitivity of 72% and a specificity of 71% for detection of the presence of haemodynamic improvement (i.e. a CI improvement >15%). The relation between CI improvement and viable tissue was similar at follow-up. CONCLUSION: A correlation was found between the extent of viable tissue and the haemodynamic response to CRT in patients with ischaemic cardiomyopathy, suggesting that FDG PET imaging may be useful to discriminate between responders and non-responders to CRT.
PURPOSE: Although resynchronisation therapy (CRT) is a promising addition to heart failure therapy, a substantial number of patients do not respond to CRT. As FDG PET has routinely been used for prediction of improvement after revascularisation in ischaemic cardiomyopathy, it was hypothesised that there is also a relationship between the extent of viable tissue and improvement as a result of CRT. METHODS: Thirty-nine patients with ischaemic cardiomyopathy (ejection fraction 27 +/- 9%) and a wide QRS complex underwent temporary pacing to determine the optimal pacing combination, i.e. that with the highest increase in cardiac index (CI) compared with baseline (measured by Doppler echocardiography). All patients also underwent FDG PET imaging. In 19 patients, CI measurements were repeated 10-12 weeks after permanent biventricular pacemaker implantation. RESULTS: Echocardiography (13-segment model) showed a mean of 9.8 +/- 1.6 dyssynergic segments, with preserved FDG uptake in 4.1 +/- 2.4 segments. CI improvement at the optimal pacing site was 20 +/- 9%. There was a linear relationship between the extent of viable tissue and CI improvement during pacing (p < 0.001). Using a cut-off value of more than three viable segments (ROC analysis), FDG PET had a sensitivity of 72% and a specificity of 71% for detection of the presence of haemodynamic improvement (i.e. a CI improvement >15%). The relation between CI improvement and viable tissue was similar at follow-up. CONCLUSION: A correlation was found between the extent of viable tissue and the haemodynamic response to CRT in patients with ischaemic cardiomyopathy, suggesting that FDG PET imaging may be useful to discriminate between responders and non-responders to CRT.
Authors: Sylvain Reuter; Stephane Garrigue; S Serge Barold; Pierre Jais; Meleze Hocini; Michel Haissaguerre; Jacques Clementy Journal: Am J Cardiol Date: 2002-02-01 Impact factor: 2.778
Authors: Stephane Lafitte; Stephane Garrigue; Jean-Marie Perron; Pierre Bordachar; Sylvain Reuter; Pierre Jaïs; Michel Haïssaguerre; Jacques Clementy; Raymond Roudaut Journal: Eur J Heart Fail Date: 2004-03-01 Impact factor: 15.534
Authors: M J Knuuti; M Saraste; P Nuutila; R Härkönen; U Wegelius; A Haapanen; J Bergman; M Haaparanta; T Savunen; L M Voipio-Pulkki Journal: Am Heart J Date: 1994-04 Impact factor: 4.749
Authors: Pierre Bordachar; Stephane Lafitte; Sylvain Reuter; Prashanthan Sanders; Pierre Jaïs; Michel Haïssaguerre; Raymond Roudaut; Stephane Garrigue; Jacques Clementy Journal: J Am Coll Cardiol Date: 2004-12-07 Impact factor: 24.094
Authors: Sebastian Lehner; Christopher Uebleis; Franziska Schüßler; Alexander Haug; Stefan Kääb; Peter Bartenstein; Serge D Van Kriekinge; Guido Germano; Heidi Estner; Marcus Hacker Journal: Eur J Nucl Med Mol Imaging Date: 2013-08-01 Impact factor: 9.236
Authors: Niti R Aggarwal; Matthew W Martinez; Bernard J Gersh; Panithaya Chareonthaitawee Journal: Nat Rev Cardiol Date: 2009-11-03 Impact factor: 32.419
Authors: Sebastian Lehner; Christian Sussebach; Andrei Todica; Christopher Uebleis; Stefan Brunner; Peter Bartenstein; Serge D Van Kriekinge; Guido Germano; Marcus Hacker Journal: J Nucl Cardiol Date: 2014-03-15 Impact factor: 5.952
Authors: Gerrina Ruiter; Yeun Ying Wong; Pieter Raijmakers; Marc C Huisman; Adriaan A Lammertsma; Paul Knaapen; Frances S de Man; Nico Westerhof; Willem J van der Laarse; Anton Vonk-Noordegraaf Journal: Pulm Circ Date: 2013-11-18 Impact factor: 3.017
Authors: Gerhard Wikstrom; Carina Blomström-Lundqvist; Bertil Andren; Stefan Lönnerholm; Per Blomström; Nick Freemantle; Thomas Remp; John G F Cleland Journal: Eur Heart J Date: 2009-01-24 Impact factor: 29.983